(Q48215959)

9 February 2018

title

Magnetic resonance imaging in the evaluation of clinical trials in multiple sclerosis (English)

1 reference

9 February 2018

0 references

Paty DW

1

1 reference

9 February 2018

Li DK

2

1 reference

9 February 2018

Oger JJ

3

1 reference

9 February 2018

Kastrukoff L

4

1 reference

9 February 2018

Koopmans R

5

1 reference

9 February 2018

Tanton E

6

1 reference

9 February 2018

Zhao GJ

7

1 reference

9 February 2018

publication date

1 January 1994

1 reference

9 February 2018

published in

Annals of Neurology

1 reference

9 February 2018

volume

36 Suppl

1 reference

9 February 2018

page(s)

S95-6

1 reference

9 February 2018

Epidemiology, education, and the ecology of Alzheimer's disease.

cites work

1 reference

https://api.crossref.org/works/10.1002%2FANA.410360721

The lesion of multiple sclerosis: imaging of acute and chronic stages

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410360721

Systemic lymphoblastoid interferon therapy in chronic progressive multiple sclerosis. I. Clinical and MRI evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410360721

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410360721

Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410360721

21 January 2018

Identifiers

DOI

10.1002/ANA.410360721

1 reference

9 February 2018

release_jtoprjxzojahll4ckv3dkopsge

Fatcat ID

0 references

1 reference

9 February 2018